| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |